MDT

Medtronic plc. Ordinary Shares (MDT)

Stock · NYSE · Health Care

$94.75as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

MiniMed completes separation from Medtronic. Medtronic has finalized the separation of its MiniMed insulin pump business, which is now operating as an independent company with a new board of directors. This corporate restructuring marks a significant shift in Medtronic's portfolio structure. Meanwhile, the company was named to the TIME Best Inventions of 2026 list for its Stealth AXiS surgical system and Corsano wearable, highlighting continued innovation in its remaining product lines.

Active signals

Support level
$85.45
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus

What MDT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Bollinger Band Breakout27+1.4%59%
200-Day Moving Average TouchActive now24-0.1%50%
Bollinger Band Breakdown24-1.5%46%
Volume Spike17+1.5%53%
Any 20-session window (baseline)+0.4%53%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About MDT

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, an…

Sector
Health Care
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Employees
95,000

Fundamentals

1-day range
$93.96$96.24
Market cap
$109.98B
P/E (trailing)
23.15
P/E (forward)
14.89
EPS (trailing)
$4.06
Dividend yield
3.50%
Beta
0.59
Avg. volume
15.48M
Ex-dividend date
September 25, 2026
Dividend pay date
October 16, 2026
52-week range
$73.31$106.33
Next earnings: November 17, 2026 · EPS estimate $1.33confirmed

How Medtronic plc. Ordinary Shares Makes Money

Where the revenue actually goes — FY2026 annual results

market-wall.comTotalRevenue$36.36BNet Income$4.80B (13%)Cost of Revenue$12.72B (35%)SG&A$11.78B (32%)Other$5.76B (16%)Tax$1.30B (4%)MDT

Source: 10-K filed Jun 18, 2026 · via SEC EDGAR / Finnhub

Gross Profit$23.64B(65%)
Operating Income$6.47B(18%)

Forecasts

25 analyst ratings

Buy 68%
Hold 32%
Sell 0%
1-year price forecast
High
$121
+27.7%
Median
$106
+11.9%
Low
$85
-10.3%

Medtronic plc. Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • MDT
    Medtronic plc. Ordinary Shares
    $94.75
    ▼ 0.73%
    Market cap $109.98BP/E 23.15
    $73.31$106.33
  • LIVN
    LivaNova PLC Ordinary Shares
    $77.58
    ▼ 1.17%
    Market cap $4.16BP/E 22.41
    $48.82$85.76
  • TMDX
    TransMedics Group Inc. Common Stock
    $70.78
    ▼ 7.50%
    Market cap $2.78BP/E 17.33
    $60.11$156
  • AXGN
    Axogen Inc. Common Stock
    $34.62
    ▼ 2.83%
    Market cap $2.38BP/E —
    $15.27$52.91
  • CNMD
    CONMED Corporation Common Stock
    $46.72
    ▼ 0.89%
    Market cap $1.49BP/E 25.13
    $31.44$53.66
  • INMD
    InMode Ltd. Ordinary Shares
    $14.16
    ▼ 1.12%
    Market cap $957.98MP/E 10.66
    $12.72$16.67
  • CBLL
    CeriBell Inc. Common Stock
    $25.04
    ▼ 9.41%
    Market cap $692.45MP/E —
    $10.85$26.63

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
910.6K
Disposed
3.2K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.